AMD — Oct 29, 2024 release
Fiscal 2024 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000002488-24-000161
Showing in the filing
Operating Expenses
“~$2.05 Billion”
Period
Q4 FY2024
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 7
Revenue for Q4 FY2024
“~$7.5 Billion, +/- $300 Million”
Gross Margin for Q4 FY2024
“~54.0%”
Operating Expenses for Q4 FY2024
“~$2.05 Billion”
Interest Expense/Other Income (Expense), net for Q4 FY2024
“~$17 Million”
Effective Tax Rate for Q4 FY2024
“~13% of pre-tax income”
Projected non-GAAP tax rate for FY2024
“13%”
Diluted Share Count for Q4 FY2024
“~1.64 Billion shares”
Exhibit 99.1 · the passage around this item
… earlier in the release
$612 Million a year ago $1.2B Primarily due to lower revenue
20 Q3 2024 FINANCIAL RESULTS – OCTOBER 29, 2024 ($ in millions) Q4’24 Revenue ~$7.5 Billion, +/- $300 Million Gross Margin ~54.0% Operating Expenses ~$2.05 Billion Interest Expense/Other Income (Expense), net ~$17 Million Effective Tax Rate ~13% of pre-tax income Diluted Share Count² ~1.64 Billion shares FINANCIAL OUTLOOK – NON-GAAP1 1. 1. See Cautionary Statement on Slide 2. These forward-looking outlook statements and non-GAAP measures are based on current expectations as of October 29, 2024, and assumptions and beliefs that involve numerous risks and uncertainties. AMD undertakes no intent or obligation to publicly update or revise its outlook statements as a result of new information, future events or otherwise, except as may be required by law. All items, except revenue, are on a non-GAAP basis. Adjustments to arrive at the GAAP financial outlook typically include stock-based compensation, amortization of acquired intangible assets, income tax provision, and other non-recurring items such as impairment charges and acquisition-related costs. The timing and impact of such adjustments are dependent on future events that are typically uncertain or outside of AMD's control, therefore, a reconciliation to equivalent GAAP measures is not practicable at this time. 2. 2. Refer to Diluted Share Count overview in the Appendices
21
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.